PNC FINANCIAL SERVICES GROUP, INC. - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$87,301
-23.6%
9,317
+99.9%
0.00%
Q2 2023$114,334
+22.2%
4,661
+15.9%
0.00%
Q1 2023$93,570
-7.8%
4,021
+0.3%
0.00%
Q4 2022$101,443
+407.2%
4,008
+274.2%
0.00%
Q3 2022$20,000
-82.5%
1,071
-75.8%
0.00%
Q2 2022$114,000
+11300.0%
4,433
+16950.0%
0.00%
Q3 2020$1,000
-87.5%
26
-88.0%
0.00%
Q1 2020$8,0002160.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
SB INVESTMENT ADVISERS (UK) LTD 22,616,666$284,405,0003.12%
INDUS CAPITAL PARTNERS, LLC 681,936$8,575,0001.68%
Alphabet Inc. 1,666,666$20,958,0001.27%
Temasek Holdings (Private) Ltd 5,499,999$69,162,0000.45%
Board of Trustees of The Leland Stanford Junior University 38,905$490,0000.06%
Baillie Gifford 500,000$6,287,0000.01%
Marshall Wace North America L.P. 74,898$941,0000.01%
Capital International Investors 983,300$12,365,0000.00%
Blackstone Inc. 35,000$440,0000.00%
Tower Research Capital LLC (TRC) 1,908$24,0000.00%
View complete list of VIR BIOTECHNOLOGY INC shareholders